Trials / Not Yet Recruiting
Not Yet RecruitingNCT07176156
Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 373 (estimated)
- Sponsor
- University Ghent · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Suicide remains a serious public health issue in Flanders. Every day, nearly three people die by suicide, and many more attempt it or struggle with suicidal thoughts. The Zelfmoordlijn 1813 is a free and confidential helpline that offers support to people in crisis through phone, chat, and email. In 2024, volunteers had over 23,000 conversations, including nearly 3,000 via chat. This study, led by the Flemish Centre of Expertise in Suicide Prevention (VLESP) in collaboration with the Centre for Suicide Prevention (CPZ), aims to better understand how people experience the chat service of the Zelfmoordlijn 1813. While previous research has looked at the impact of phone conversations, little is known about how chat conversations affect suicidal thoughts and feelings. To explore this, people who contact the chat service will be invited to fill out a short questionnaire before and after their conversation. These questionnaires take about 3 minutes each and are completely voluntary. They ask about feelings like hopelessness, crisis, and perceived support, as well as satisfaction with the chat. The goal is to improve the quality of chat-based crisis support and ensure that people in emotional distress receive the best possible help. This research will help strengthen suicide prevention efforts in Flanders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Observational one-time questionnaire study without intervention |
Timeline
- Start date
- 2025-09-23
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-09-16
- Last updated
- 2025-09-16
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07176156. Inclusion in this directory is not an endorsement.